CORC

在结果中检索

CORC

浏览/检索结果: 共289条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Question Answering Algorithm for Grid Fault Diagnosis based on Graph Neural Network 会议论文
Guangzhou, China, 2022-12
作者:  Yu Yahan;  Wang Yun;  Zhang Guigang;  Yang Yi;  Wang Jian
收藏  |  浏览/下载：9/0  |  提交时间：2023/06/02
Measurement of very-high-energy diffuse gamma-ray emission from Galactic plane with LHAASO-KM2A 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Zhang, Rui;  Zhao, Shiping;  Zhang, Yi;  Yuan, Qiang;  Cao, Zhen
收藏  |  浏览/下载：17/0  |  提交时间：2023/01/23
Observations of extended very-high-energy halos around Geminga and Monogem with the LHAASO-KM2A 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Guo, Yingying;  Zhang, Yi;  Yuan, Qiang;  Hu, Hongbo;  Cao, Zhen
收藏  |  浏览/下载：19/0  |  提交时间：2023/01/23
Species monitoring using unmanned aerial vehicle to reveal the ecological role of Plateau pika in maintaining vegetation diversity on the northeastern Qinghai-Tibetan Plateau 会议论文
作者:  Qin, Yu;  Sun, Yi;  Zhang, Wei;  Qin, Yan;  Chen, Jianjun
收藏  |  浏览/下载：10/0  |  提交时间：2020/12/18
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：46/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：37/0  |  提交时间：2019/12/05
Safety and efficacy of repeated intra-hepatic artery and intravenous infusion of ET140202, a novel anti-AFP/MHC complex T-cell, in advanced hepatocellular carcinoma. 会议论文
作者:  Peng, Min;  Li, Na;  Chang, Chelsea;  Yao, Yi;  Xu, Bin
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
Safety and efficacy of repeated intra-hepatic artery and intravenous infusion of ET140202, a novel anti-AFP/MHC complex T-cell, in advanced hepatocellular carcinoma. 会议论文
作者:  Peng, Min;  Li, Na;  Chang, Chelsea;  Yao, Yi;  Xu, Bin
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace